Emergent BioSolutions, Inc. (EBS)
Emergent BioSolutions Market Cap : 282.41M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 287.79M |
| November 16, 2026 | 298.05M |
| November 13, 2026 | 297.03M |
| November 12, 2026 | 302.16M |
| November 11, 2026 | 309.85M |
| November 10, 2026 | 310.36M |
| November 09, 2026 | 312.93M |
| November 06, 2026 | 310.88M |
| November 05, 2026 | 300.10M |
| November 04, 2026 | 302.67M |
| November 03, 2026 | 320.62M |
| November 02, 2026 | 330.37M |
| October 30, 2026 | 349.35M |
| October 29, 2026 | 370.39M |
| October 28, 2026 | 363.72M |
| October 27, 2026 | 342.17M |
| October 26, 2026 | 325.24M |
| October 23, 2026 | 319.60M |
| October 22, 2026 | 319.60M |
| October 21, 2026 | 318.06M |
| October 20, 2026 | 322.68M |
| October 19, 2026 | 326.27M |
| October 16, 2026 | 327.29M |
| October 15, 2026 | 368.33M |
| October 14, 2026 | 354.48M |
| Date | Value |
|---|---|
| October 13, 2026 | 354.48M |
| October 12, 2026 | 358.07M |
| October 09, 2026 | 362.18M |
| October 08, 2026 | 349.35M |
| October 07, 2026 | 362.69M |
| October 06, 2026 | 356.54M |
| October 05, 2026 | 371.41M |
| October 02, 2026 | 324.73M |
| October 01, 2026 | 326.78M |
| September 30, 2026 | 338.58M |
| September 29, 2026 | 355.00M |
| September 28, 2026 | 351.92M |
| September 25, 2026 | 348.33M |
| September 24, 2026 | 347.30M |
| September 23, 2026 | 342.17M |
| September 22, 2026 | 346.79M |
| September 21, 2026 | 336.02M |
| September 18, 2026 | 348.84M |
| September 17, 2026 | 360.13M |
| September 16, 2026 | 346.28M |
| September 15, 2026 | 326.27M |
| September 14, 2026 | 327.29M |
| September 11, 2026 | 319.60M |
| September 10, 2026 | 301.13M |
| September 09, 2026 | 291.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 135.97B |
| Arcturus Therapeutics Holdings, Inc. | 228.26M |
| Capricor Therapeutics, Inc. | 466.86M |
| Travere Therapeutics, Inc. | 4.806B |
| Syndax Pharmaceuticals, Inc. | 771.66M |
Market Cap Related Metrics
| PS Ratio | 0.4490 |
| Price to Book Value | 0.9017 |
| Price to Free Cash Flow | 1.547 |
| Price | 5.505 |
| Earnings Yield | -92.59% |
| Operating PE Ratio | 9.081 |